Advertising Claims for Anxiety and Depression

This trial examines how online cannabis ads affect buying habits, particularly among individuals experiencing anxiety or depression. It investigates whether claims about cannabis aiding mental health increase purchase intent and if warnings about potential negative effects alter decisions. Participants will shop in a simulated online store featuring various ads to determine what influences their choices. Individuals who occasionally use cannabis and experience anxiety or depression symptoms may be well-suited for this study. The goal is to develop better marketing regulations to protect mental well-being. As an unphased trial, this study provides a unique opportunity to contribute to research that could lead to more responsible advertising practices.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

Research has shown that claims about cannabis aiding mental health issues like anxiety or depression lack strong support from safety data. Clear evidence proving cannabis's safety or effectiveness for these conditions is absent. This trial examines how cannabis advertising influences buying habits, but it's important to note that cannabis use can sometimes worsen anxiety and depression, especially with heavy use.

Researchers are excited about this trial because it explores how different advertising claims might impact perceptions of anxiety and depression treatments. Unlike standard care, which often involves medications like SSRIs or therapy, this trial is investigating the power of messaging. The PAC Store focuses on positive claims like "Calming" and "Helps with: Stress," potentially enhancing the perceived benefits of a product. Meanwhile, the WL Store includes warnings about THC's negative effects, which could influence consumer choices differently. This trial could uncover how strategic messaging affects decision-making and treatment outcomes, offering new insights into mental health product marketing.

This trial will compare different advertising claims related to cannabis products. Research has shown that cannabis is often promoted as helpful for mental health issues like anxiety and depression. However, studies have not consistently proven its effectiveness in treating these conditions. Some evidence suggests that cannabis might temporarily relieve stress and anxiety, but it can also sometimes worsen depression and anxiety, especially when THC (the mind-altering component of cannabis) is involved. The effects vary depending on the individual and their specific mental health situation. Overall, while cannabis might seem to help some people, scientific evidence does not strongly support its use for treating anxiety and depression.⁶⁷⁸⁹¹⁰